A Single-center, Open-label, Ascending Single- and Multiple-oral Dose Study to Evaluate the Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

Trial Profile

A Single-center, Open-label, Ascending Single- and Multiple-oral Dose Study to Evaluate the Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Aortic valve stenosis; Atrial fibrillation; Heart failure; Left ventricular hypertrophy; Long QT syndrome; Myocardial ischaemia; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Menarini Asia-Pacific
  • Most Recent Events

    • 13 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top